Share market update: Pharma shares advance; Sun Pharma rises 2%
The Nifty Pharma index was trading 0.39 per cent up at 8085.25 .
Citi turns positive on pharma; Aurobindo, Biocon top bets
Citi has upgraded Dr Reddy Laboratories to ‘buy’ from ‘sell’ earlier. It has a target of Rs 3,380 on the stock.
Cipla, PAG eye Wockhardt’s formulations business
Wockhardt employs more than 7,000 people and has a presence in the US, Britain, Ireland, Switzerland, France, Mexico, Russia and other countries. It has manufacturing and research facilities in India, the US and Britain, and a plant in Ireland.
Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall
"We understand from Mylan NV's press release dated January 8, 2020, that Mylan Pharmaceuticals has initiated a voluntary recall of three lots of Nizatidine Capsules, USP (150 mg and 300 mg strengths) due to detected trace amounts of impurity...," Solara Active Pharma Sciences in a filing to BSE.
Wockhardt rallies after revival plan gets a boost from drug nod
Investors cheered the news, sending Wockhardt’s shares up by 5.7 per cent on the BSE on Thursday.
Alembic Pharma jumps 3% as JV firm completes USFDA inspection
Alembic Pharma manufactures and markets generic pharmaceutical products across the globe.
Stocks in the news: Gati, Bharti Airtel, Alembic Pharma, Aster DM and DHFL
GMR Infra has raised Rs 2,000 crore debt through nonconvertible debentures from Tata Sons.
Aurobindo Pharma Inc recalls Mirtazapine tablets in US
The product is being recalled due to a label error on declared strength. Bottles labelled as Mirtazapine 7.5 mg may contain 15 mg tablets, as per the company's announcement posted on the website of the United States Food and Drug Administration (USFDA).
ICICI Pru has just offloaded Airtel, Voda; picked bank, power, pharma stocks
Overall, it increased stakes in over 350 companies from across sectors in December.
Financials, auto, IT & pharma to lead Q3 earnings: Deven Choksey
Banks are monetising their assets, selling part stakes in their investment portfolios and getting out of the non-core activities. They would have better profits to talk about. Financials clearly look winners in this particular quarter results. Auto and auto ancillaries would probably have a relatively better quarter on a sequential basis. Many commodity stocks are likely to show better performance.
Share market update: Pharma shares dip; Piramal Enterprises down 1%
The Nifty Pharma index was trading 0.49 per cent down at 7997.4.
Sun, Aurobindo and Dr Reddy’s are CLSA’s top picks in pharma
Here’s what CLSA is saying about its best ideas for 2020 in the pharma space.
USFDA classifies inspection of Lupin's Tarapur facility as 'Official Action Indicated'
According to FDA's definitions, Official Action Indicated means "objectionable conditions were found and regulatory administrative sanctions by FDA are indicated" during inspections. The company, however, said that it does not believe this inspection classification will have an impact on disruption of supplies or the existing revenues from operations of this facility.
Market at record high: Sensex tops 42,000 for first time; Nifty nears 12,400
Barring auto and metal, all sectoral indices on NSE were trading with gains.
'BUY' or 'SELL' ideas from experts for Thursday, 16 January, 2020
Aurobindo Pharma is a 'Buy' call with a target price of Rs 535 and a stop loss of Rs 472.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service